Urs B. Hagemann
Berlin, BE 13342, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.
Journal: Molecular pharmaceutics
Published: March 03, 2026
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.
Journal: International journal of molecular sciences
Published: November 13, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 01, 2023
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.
Journal: Molecular cancer therapeutics
Published: January 18, 2023
Targeted thorium-227 conjugates as treatment options in oncology.
Journal: Frontiers in medicine
Published: October 15, 2022
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2021
89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 19, 2021
In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: May 20, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2021
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: April 08, 2020
Last Updated: 09/26/2026